Prodotti GS / Area HIV
BICSTar: Biktarvy® shows high efficacy against HIV in real-world setting
![Immagine News](/media/0icnkhat/cat-1.jpg?center=0.55476190476190479,0.25&mode=crop&width=722&height=442)
Gilead’s Biktarvy demonstrated a consistently high efficacy of over 95 percent in analyses of the ongoing real-world cohort BICSTaR study.
Additional information, at the following link: https://www.europeanpharmaceuticalreview.com/news/164962/biktarvy-shows-high-efficacy-against-hiv-in-real-world-setting/
Grazie per il tuo feedback!